The University of Texas System

Other

Access Business Group International LLC

Zbigniew Walaszek

Thomas J Slaga

Margaret Hanausek-Walaszek

Haeri Roh-Schmidt

John V Scimeca

Kevin W Gellenbeck

Russell K Randolph

James R Mayne

Lynne Marie Connor

Gregory S Evans

Margaret Hanausek

Gregory Grochoski

Margaret Hanauek

Methods of reducing cellular damage are described that include (a) administering to the mammal an oral dosage form comprising a therapeutically effective amount of a first antioxidant, and (b) administering to the mammal a topical dosage form comprising a therapeutically effective amount of a second antioxidant, wherein at least one of the first antioxidant and the second antioxidant comprises acerola concentrate. Methods of inhibiting free radical production, methods of scavenging free radicals, and kits for reducing cellular damage are also described.

Methods and kits for reducing cellular damage, inhibiting free radical production and scavenging free radicals

This invention relates to the isolation, identification and sequencing of a cancer associated protein, preparation of hybridization probes therefrom, preparation of antibodies thereto, and methods of cancer risk assessment and diagnosis.

Tumor marker protein for cancer risk assessment

The present invention provides a formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation. More specifically, the present invention provides a method for administering a formula including glucaric acid or a pharmaceutically acceptable salt thereof for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation in humans and animals. It has been determined that glucaric acid and pharmaceutically acceptable salts thereof significantly lower the total and LDL level of serum cholesterol and inhibit cellular hyperproliferation when administered in therapeutic amounts. It is intended that glucaric acid or a pharmaceutically acceptable salt thereof is employed alone or in combination with other medicinal agents for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation.

Formula and method for the prevention and treatment of

A tumor-associated marker protein was purified and antibodies thereto developed for cancer diagnosis and assessment of cancer risk associated with the long-term use of synthetic steroid hormones, both contraceptive and non-contraceptive, and other drugs that exhibit tumor promotional properties. The marker protein and antibodies thereto provided are interspecies immunologically cross-reactive. In summary, the marker p65 tumor-associated factor of the present invention has the following characteristics:

Tumor marker protein and antibodies thereto for cancer risk assessment

Growing community of inventors

Bastrop, TX, United States of America

Zbigniew Walaszek